53 State Street 40th Floor,
Boston, Massachusetts 02109
United States
(617) 918-4000
www.leerink.com
Leerink Partners is an investment bank specializing in the healthcare sector. Firm services include capital markets access, M&A advisory, and research. Leerink Swann LLC has offices in Boston, New York City, and San Francisco.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T |
|---|---|---|---|---|---|---|---|
| Buyside (0.4/yr) | 11 | 2 | - | - | - | - | 13 |
| Sellside (0.6/yr) | 23 | 2 | - | 1 | - | - | 26 |
| 39 | |||||||
| Target Company | Date | Value | Type |
|---|---|---|---|
| Sign-up to View | 2023-08-09 | 109M USD | Life Science |
| Sign-up to View | 2021-07-29 | - | Business Services |
| Sign-up to View | 2021-06-25 | 820M USD | Healthcare Services |
| Sign-up to View | 2021-05-04 | 185M USD | Life Science |
| Sign-up to View | 2021-03-09 | 164M USD | Life Science |
| Sign-up to View | 2020-09-21 | - | Information Technology |
| Sign-up to View | 2020-06-22 | 90M USD | Medical Products |
| Sign-up to View | 2020-02-03 | 60M USD | Medical Products |
| Sign-up to View | 2020-01-10 | 1.1B USD | Life Science |
| Sign-up to View | 2020-01-06 | 35M USD | Medical Products |
| View All >> | |||
| Sector | # | Value | |
|---|---|---|---|
| Life Science | Sign-up to View | ||
| Medical Products | Sign-up to View | ||
| Healthcare Services | Sign-up to View | ||
| Information Technology | Sign-up to View | ||
| Business Services | Sign-up to View | ||
| Total | Sign-up to View | ||
| State/Country | # | Value | |
|---|---|---|---|
| United States | Sign-up to View | ||
| Massachusetts | Sign-up to View | ||
| California | Sign-up to View | ||
| New Jersey | Sign-up to View | ||
| Texas | Sign-up to View | ||
| Montana | Sign-up to View | ||
| Washington | Sign-up to View | ||
| North Carolina | Sign-up to View | ||
| Maryland | Sign-up to View | ||
| Kentucky | Sign-up to View | ||
| Florida | Sign-up to View | ||
| United Kingdom | Sign-up to View | ||
| Domestic | Sign-up to View | ||
| Cross-border | Sign-up to View | ||
| Total | Sign-up to View | ||
| Type | # | Value | |
|---|---|---|---|
| Add-on Acquisition | Sign-up to View | ||
| Merger | Sign-up to View | ||
| Divestiture | Sign-up to View | ||
| Recapitalization | Sign-up to View | ||
| Growth Capital | Sign-up to View | ||
| Total | Sign-up to View | ||
| PE Firms (1) | Deals |
|---|---|
|
Sign-up to View |
1 |
| Corporate (37) | Deals |
|---|---|
|
Sign-up to View |
2 |
|
Sign-up to View |
1 |
|
Sign-up to View |
1 |
| Value | # | TOTAL |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
NPS Pharmaceuticals, Inc. $5.2B (2015-02-21) |
|
